A Clearer Path from Evaluation to Implementation

Evologics may support both direct purchasing and authorized distribution. The available pathway depends on the product, facility, territory, and applicable agreement.

Yes. Evologics can assemble available product, clinical, quality, operational, and financial information for a facility's value analysis process.

No. Regulatory status varies by product. The portfolio may include human cells, tissues, and cellular and tissue-based products, medical devices, synthetic products, and other categories. Request product-specific regulatory information rather than relying on a portfolio-wide classification. FDA establishment registration or product listing does not, by itself, mean that a product is FDA approved.

Evologics can provide or coordinate product identifiers and documentation available from the applicable processor or manufacturer. Each facility is responsible for maintaining its own tissue tracking, recipient documentation, and final-disposition records.

Consignment may be available for approved products and accounts under a written agreement. Eligibility depends on utilization, product type, storage capability, account status, and operational requirements.

No. Coding, coverage, and payment depend on the individual procedure, payer, patient, facility, documentation, and applicable policies. Any coding information supplied by Evologics is general educational information.

On-site and virtual education may be available based on facility needs, product, geography, and educator availability.

Do not use a product when its condition or integrity is uncertain. Quarantine it according to facility policy and contact Evologics promptly with the product name, catalog number, lot or serial information, expiration date, and a description of the concern. Do not submit patient-identifying information through the general website form.